Annual Current Assets
$637.28 M
+$275.91 M+76.35%
31 December 2023
Summary:
Madrigal Pharmaceuticals annual total current assets is currently $637.28 million, with the most recent change of +$275.91 million (+76.35%) on 31 December 2023. During the last 3 years, it has risen by +$352.12 million (+123.48%). MDGL annual current assets is now at all-time high.MDGL Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$1.06 B
-$28.06 M-2.57%
30 September 2024
Summary:
Madrigal Pharmaceuticals quarterly total current assets is currently $1.06 billion, with the most recent change of -$28.06 million (-2.57%) on 30 September 2024. Over the past year, it has increased by +$828.20 million (+351.72%). MDGL quarterly current assets is now -2.57% below its all-time high of $1.09 billion, reached on 30 June 2024.MDGL Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +76.3% | +351.7% |
| 3 y3 years | +123.5% | +251.1% |
| 5 y5 years | +31.3% | +133.6% |
MDGL Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +134.6% | -2.6% | +577.0% |
| 5 y | 5 years | at high | +134.6% | -2.6% | +577.0% |
| alltime | all time | at high | >+9999.0% | -2.6% | >+9999.0% |
Madrigal Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.06 B(-2.6%) |
| June 2024 | - | $1.09 B(+1.7%) |
| Mar 2024 | - | $1.07 B(+68.5%) |
| Dec 2023 | $3.27 M(+171.5%) | $637.28 M(+170.6%) |
| Sept 2023 | - | $235.47 M(-21.9%) |
| June 2023 | - | $301.60 M(-9.0%) |
| Mar 2023 | - | $331.28 M(-8.3%) |
| Dec 2022 | $1.20 M(-27.0%) | $361.37 M(+130.0%) |
| Sept 2022 | - | $157.11 M(-26.8%) |
| June 2022 | - | $214.55 M(-3.0%) |
| Mar 2022 | - | $221.17 M(-18.6%) |
| Dec 2021 | $1.65 M(-10.0%) | $271.68 M(-10.3%) |
| Sept 2021 | - | $302.96 M(-7.1%) |
| June 2021 | - | $326.07 M(+5.9%) |
| Mar 2021 | - | $308.05 M(+8.0%) |
| Dec 2020 | $1.83 M(-1.5%) | $285.16 M(-15.5%) |
| Sept 2020 | - | $337.60 M(-12.7%) |
| June 2020 | - | $386.60 M(-5.6%) |
| Mar 2020 | - | $409.49 M(-7.0%) |
| Dec 2019 | $1.86 M(+718.9%) | $440.20 M(-3.3%) |
| Sept 2019 | - | $455.32 M(-2.9%) |
| June 2019 | - | $468.79 M(-2.0%) |
| Mar 2019 | - | $478.39 M(-1.4%) |
| Dec 2018 | $227.00 K(-24.6%) | $485.20 M(-0.8%) |
| Sept 2018 | - | $489.31 M(-0.4%) |
| June 2018 | - | $491.27 M(+168.2%) |
| Mar 2018 | - | $183.20 M(-4.6%) |
| Dec 2017 | $301.00 K(>+9900.0%) | $192.01 M(+206.1%) |
| Sept 2017 | - | $62.72 M(-7.7%) |
| June 2017 | - | $67.95 M(+68.4%) |
| Mar 2017 | - | $40.35 M(-2.1%) |
| Dec 2016 | $3000.00(>+9900.0%) | $41.21 M(+0.0%) |
| Sept 2016 | - | $41.19 M(-8.1%) |
| June 2016 | - | $44.84 M(-14.8%) |
| Mar 2016 | - | $52.60 M(>+9900.0%) |
| Dec 2015 | $0.00 | $363.60 K(-99.6%) |
| Sept 2015 | - | $90.23 M(-10.3%) |
| June 2015 | - | $100.55 M(+29.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $77.97 M(-21.5%) |
| Dec 2014 | $1.33 M(-55.1%) | $99.35 M(-18.7%) |
| Sept 2014 | - | $122.19 M(+6.9%) |
| June 2014 | - | $114.32 M(+42.2%) |
| Mar 2014 | - | $80.39 M(-12.8%) |
| Dec 2013 | $2.96 M(+81.5%) | $92.24 M(+68.5%) |
| Sept 2013 | - | $54.74 M(-23.8%) |
| June 2013 | - | $71.84 M(-21.8%) |
| Mar 2013 | - | $91.87 M(-9.4%) |
| Dec 2012 | $1.63 M(-19.9%) | $101.39 M(+81.2%) |
| Sept 2012 | - | $55.94 M(+23.0%) |
| June 2012 | - | $45.49 M(-21.6%) |
| Mar 2012 | - | $58.00 M(+44.0%) |
| Dec 2011 | $2.04 M(-20.0%) | $40.29 M(-22.6%) |
| Sept 2011 | - | $52.02 M(-18.4%) |
| June 2011 | - | $63.72 M(+56.3%) |
| Mar 2011 | - | $40.76 M(-20.9%) |
| Dec 2010 | $2.55 M(-41.3%) | $51.52 M(-6.0%) |
| Sept 2010 | - | $54.80 M(+11.0%) |
| June 2010 | - | $49.38 M(-16.2%) |
| Mar 2010 | - | $58.93 M(+32.2%) |
| Dec 2009 | $4.34 M(-28.1%) | $44.57 M(-15.8%) |
| Sept 2009 | - | $52.94 M(-16.0%) |
| June 2009 | - | $63.01 M(-26.7%) |
| Mar 2009 | - | $85.98 M(-5.7%) |
| Dec 2008 | $6.03 M(+6.7%) | $91.22 M(+7.4%) |
| Sept 2008 | - | $84.95 M(+4.9%) |
| June 2008 | - | $80.98 M(-20.0%) |
| Mar 2008 | - | $101.27 M(-13.4%) |
| Dec 2007 | $5.65 M(-21.1%) | $117.00 M(+131.6%) |
| Sept 2007 | - | $50.51 M(-23.4%) |
| June 2007 | - | $65.92 M(-16.9%) |
| Mar 2007 | - | $79.35 M(+66.6%) |
| Dec 2006 | $7.16 M(-13.3%) | $47.63 M(-20.6%) |
| Sept 2006 | - | $60.00 M(-4.7%) |
| Dec 2005 | $8.26 M(+37.7%) | $62.95 M(-43.3%) |
| Mar 2005 | - | $111.05 M |
| Dec 2004 | $6.00 M(+80.3%) | - |
| Dec 2003 | $3.33 M | - |
FAQ
- What is Madrigal Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual current assets year-on-year change?
- What is Madrigal Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly current assets year-on-year change?
What is Madrigal Pharmaceuticals annual total current assets?
The current annual current assets of MDGL is $637.28 M
What is the all time high annual current assets for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual total current assets is $637.28 M
What is Madrigal Pharmaceuticals annual current assets year-on-year change?
Over the past year, MDGL annual total current assets has changed by +$275.91 M (+76.35%)
What is Madrigal Pharmaceuticals quarterly total current assets?
The current quarterly current assets of MDGL is $1.06 B
What is the all time high quarterly current assets for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly total current assets is $1.09 B
What is Madrigal Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, MDGL quarterly total current assets has changed by +$828.20 M (+351.72%)